ask="N/A"
ask_size="N/A"
average_daily_volume="39114"
bid="N/A"
bid_size="N/A"
book_value="0.49"
change="-0.09"
change_from_200_day_moving_average="-1.33"
change_from_50_day_moving_average="-0.91"
change_from_52_week_high="-6.70"
change_From_52_week_low="0.24"
change_in_percent="-3.77%"
close="2.30"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.42"
ebitda="-15.65M"
eps_estimate_current_year="-1.73"
eps_estimate_next_quarter="-0.52"
eps_estimate_next_year="-2.05"
ex_dividend_date="N/A"
float_shares="4437000"
high="2.35"
high_52_weeks="9.00"
last_trade_date="2/17/2017"
last_trade_price="2.30"
last_trade_size="239"
last_trade_time="4:00pm"
low="2.25"
low_52_weeks="2.06"
market_capitalization="19.27M"
moving_average_200_day="3.63"
moving_average_50_day="3.21"
name="VistaGen Therapeutics
Inc."
notes="N/A"
one_year_target_price="23.50"
open="2.35"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-36.66%"
percent_change_from_50_day_moving_average="-28.44%"
percent_change_from_52_week_high="-74.44%"
percent_change_from_52_week_low="+11.65%"
previous_close="2.39"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.84"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="8379000"
short_ratio="2.09"
stock_exchange="NCM"
symbol="VTGN"
volume="32210"
weeks_range_52="2.06 - 9.00"
